CrushingTheMarket

Crushing the stock market

[CrushingTheMarket @CrushingTheMark]

https://t.co/z03fF1G0PF
$CYBL $ADHC $GFAI $UCPA $SNMP $HIRU

[Stock Picks NYC @StockPicksNYC]

$GTVH slowly getting picked up, could see a major run once more investors discover this gem! 🛫

Also check out the balance sheet it’s a waaay bigger company than the current market cap 👀
#Pennystock #StocksToBuy

[CrushingTheMarket @CrushingTheMark]

$HMTXF Hemostemix CEO video interview, Thomas Smeenk also talks about what to expect this year including Phase II Clinical trial results.
https://t.co/0zfz7BYG9o
$ENZC $AMHD $XCUR $KITVF $NWBO

[CrushingTheMarket @CrushingTheMark]

$HMTXF Announced Settlement Agreement against Aspire Health Science in relation to ACP-01 in their possession. ACP-01 is a treatment of CLI, PAD, Angina, Ischemic Cardiomyopathy, Dilated Cardiomyopathy, ischemia.
https://t.co/5Qlh1Vy25H
$SABR $ATER $ONPH $INLB $LEAT $ALKS

[CrushingTheMarket @CrushingTheMark]

$HMTXF video interview; Tracy Weslosky spoke with Thomas Smeenk, CEO of Hemostemix Inc about recent news release on collaborating with world famous Dr. James Shapiro to Treat Type 1 Diabetes.
https://t.co/XHT7Yshwpw
$LEXX $QBIO $CYN $ERYP $CYIO

[CrushingTheMarket @CrushingTheMark]

$HMTXF is experiencing a phenomenal hike in share value in the past month and honestly this is just a tiny blip on a much bigger chart in the upcoming days and weeks based on their current valuation. Based on the news, co is having a breakthough year
$TPST $UEEC $NBIO $NCRA $GESI

[CrushingTheMarket @CrushingTheMark]

The intellectual property of ACP-01 mark its returns
Hemostemix Inc. $HMTXF, the ongoing dispute with Aspire Health Science, has finally met its end as all the confidential data relating to ACP01 had marked its return to Hemostemix Inc, a MAJOR milestone.
$ILUS $USGDF $CAPC $INO

[CrushingTheMarket @CrushingTheMark]

Hemostemix $HMTXF Announced a Settlement Agreement against Aspire Health Science, LLC, this is big news for HMTXF supporting a .50-.75 price per share based on the current market cap. Right now the stock is trading in the .25 range. 🛫
$CYDY $NGENF $MDNA $NCRA $SILO

[CrushingTheMarket @CrushingTheMark]

#2 most watched @Investor_Intel interview in the past weeks- MUST WATCH: $HMTXF ceo, Thomas Smeenk on Hemostemix's progress and outlook going forward! https://t.co/zggxG4GDCQ
$AVVH $SING $RLFTF $PBIO $RVVTF

[CrushingTheMarket @CrushingTheMark]

$HMTXF Discussing what makes Stem Cells such an incredible investment right now, seriously worth watching and looking into!! https://t.co/tddFi7tF9Y
$MRNA $VBIZF $NRBO $MOLN $FEMI

[CrushingTheMarket @CrushingTheMark]

Really liking $NUTX right now its a brand new play, the merger was just completed this month and its getting some look for the first time.

Also $HMTXF pretty interesting, the market cap is only 16M which is way low for a phase II clinical, and the company owns 91 patents.

[CrushingTheMarket @CrushingTheMark]

$HMTXF Hemostemix; Discussing Recent Company Updates, Market cap 9M, company owns 91 patents + phase II clinical trials...
https://t.co/9u0iIessJr
$NBIO $PMCBD $RGBP $ATVBF $QNRX

[CrushingTheMarket @CrushingTheMark]

$SEII the real reason investors are looking to either be a part of or take over the company.
https://t.co/xReA2BeeGd

[CrushingTheMarket @CrushingTheMark]

$SEII interesting stock, they own the BuddiGo grocery delivery app and their market cap is only 1.6M

Someone can scoop their app right up for that price and launch it in USA and Europe and make a killing

Heres their app Buddigo: https://t.co/Y6gAMZg76V
$AVXL $COOP $NWBO $DWAC

[CrushingTheMarket @CrushingTheMark]

$HMTXF settlement agreement news, in relation to ACP-01 in their possession (the "ACP-01 Data")
This is a major catalyst for HMTXF to support a .50-.75 per share price
https://t.co/5Qlh1Vy25H
$OBMP $VBLT $ONPH $ERYP $NKTX

[CrushingTheMarket @CrushingTheMark]

$HMTXF interesting. ACP-01 used to treat over 300 patients, now subject of randomized, placebo-controlled, double blind trial for safety, efficacy in patients with critical limb ischemia to save their limb from amputation.
https://t.co/0zfz7BYG9o
$KTRA $HALB $TSOI $GOVX $IMRN

[CrushingTheMarket @CrushingTheMark]

$EVOK granted new drug product exclusivity by the U.S. Food and Drug Administration (FDA) for GIMOTI (metoclopramide) nasal spray. 🏆

Also $HMTXF settlement agreement re-gaining all their data and property in relation to ACP-01 in their possession (the "ACP-01 Data") 🏆

[CrushingTheMarket @CrushingTheMark]

$HMTXF Hemostemix CEO video interview, Thomas Smeenk also talks about what to expect this year including Phase II Clinical trial results.
https://t.co/0zfz7BYG9o
$AVVH $CYDY $HALB $PTGX $ENTX

[CrushingTheMarket @CrushingTheMark]

$PTI FDA approved its investigational new drug application on January 18
$HMTXF Settlement agreement + positive clinical data and 91 patents
$ADGI lead monoclonal antibody has neutralization activity against Omicron.
$BBI analyst coverage with a buy rating and a $2 price target.

[CrushingTheMarket @CrushingTheMark]

$CLVS seeking FDA approval for ovarian cancer drug as a maintenance therapy.
$LGVN Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disease in Alzheimer’s & Dementia
$HMTXF announces settlement agreement against Aspire Health Science #Biotech

[CrushingTheMarket @CrushingTheMark]

$DSMTF stock could have a major run up soon, they are getting very close to winning against Ministry of Mines and Energy of Namibia.
https://t.co/5jBs1z084N
Also keep an eye on these stocks below
$NVNXF $PMETF $GOTRF $WLYYF $IMTE

[CrushingTheMarket @CrushingTheMark]

$HMTXF Hemostemix; Discussing Recent Company Updates, Market cap 9M, company owns 91 patents + phase II clinical trials...
https://t.co/9u0iIessJr
$SABS $CELZ $TRVN $MILC $HRBR